TY - JOUR
T1 - Improving surgical site infection prevention in Asia-Pacific through appropriate surveillance programs
T2 - Challenges and recommendation
AU - Russo, P. L.
AU - Saguil, E.
AU - Chakravarthy, M.
AU - Lee, K. Y.
AU - Ling, M. L.
AU - Morikane, K.
AU - Spencer, M.
AU - Danker, W.
AU - Yu, N. Y.C.
AU - Edmiston, C. E.
N1 - Funding Information:
PLR Russo, a member of the Ethicon (Johnson & Johnson) Advisory Board, Chair and Speaker at APAC Surgical Site Infection Prevention Symposium is President of the Australasian College for Infection Prevention and Control, member of the Australian COVID Evidence Taskforce Steering Committee, the Infection Control Expert Group to the Department of Health, the Australian Strategic and Technical Advisory Group on AMR, the Healthcare Associated Infection Advisory Committee to the Australian Commission on Safety and Quality in Health Care, and a member of the Australian College of Nursing. Recipient of a NHMRC Early Career Fellowship, and has received research funding from the Rosemary Norman Foundation , Cardinal Health, Australian College of Nursing and the Cabrini Institute .
Funding Information:
PLR Russo, a member of the Ethicon (Johnson & Johnson) Advisory Board, Chair and Speaker at APAC Surgical Site Infection Prevention Symposium is President of the Australasian College for Infection Prevention and Control, member of the Australian COVID Evidence Taskforce Steering Committee, the Infection Control Expert Group to the Department of Health, the Australian Strategic and Technical Advisory Group on AMR, the Healthcare Associated Infection Advisory Committee to the Australian Commission on Safety and Quality in Health Care, and a member of the Australian College of Nursing. Recipient of a NHMRC Early Career Fellowship, and has received research funding from the Rosemary Norman Foundation, Cardinal Health, Australian College of Nursing and the Cabrini Institute.The Asia Pacific Masters Surgical Site Infection Prevention Symposium was sponsored by ETHICON, a member of the Johnson & Johnson Family of Companies. In Vivo Communications received a grant from Ethicon, Inc for meeting logistics, meeting organization and editorial assistance.
Publisher Copyright:
© 2021 The Authors
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/8
Y1 - 2021/8
N2 - Background: Surgical site infections (SSIs) represent a substantial clinical and economic burden on patients and the healthcare system. The prevention of SSIs entails surveillance activities which lead to effective mitigation strategies, which are lacking across Asia Pacific (APAC). This manuscript aims to document gaps and challenges across APAC that affect the undertaking of a successful SSI surveillance activities and to provide recommendations on overcoming such challenges. Methods: A targeted literature review with relevance to APAC identified a series of salient points pertaining to SSI prevention guidelines, implementation, surveillance and outcomes, which was discussed in July 2019 at the APAC Surgical Site Infection Prevention Symposium. An expert panel, comprising eight multidisciplinary experts from APAC and the USA, subsequently amalgamated the key discussion points from the Symposium and their clinical experiences in developing this article. Results: The barriers to implementing a successful and effective APAC SSI surveillance program were identified as: (a) lack of standardized definitions, reporting methodology and accountability, (b) lack of fiscal resources, (c) reporting variability and under-reporting, and (d) lack of safety culture. Implementing an effective surveillance program in APAC will require countries to develop a well-designed and robust surveillance plan and ensure adequate training for staffs involved. Conclusion: To improve SSI prevention in the region, it is imperative to encourage implementation of national programs with standardized methodologies and accountabilities. An ongoing APAC information exchange, including data and methodologies, will enable continuous learning within the APAC region.
AB - Background: Surgical site infections (SSIs) represent a substantial clinical and economic burden on patients and the healthcare system. The prevention of SSIs entails surveillance activities which lead to effective mitigation strategies, which are lacking across Asia Pacific (APAC). This manuscript aims to document gaps and challenges across APAC that affect the undertaking of a successful SSI surveillance activities and to provide recommendations on overcoming such challenges. Methods: A targeted literature review with relevance to APAC identified a series of salient points pertaining to SSI prevention guidelines, implementation, surveillance and outcomes, which was discussed in July 2019 at the APAC Surgical Site Infection Prevention Symposium. An expert panel, comprising eight multidisciplinary experts from APAC and the USA, subsequently amalgamated the key discussion points from the Symposium and their clinical experiences in developing this article. Results: The barriers to implementing a successful and effective APAC SSI surveillance program were identified as: (a) lack of standardized definitions, reporting methodology and accountability, (b) lack of fiscal resources, (c) reporting variability and under-reporting, and (d) lack of safety culture. Implementing an effective surveillance program in APAC will require countries to develop a well-designed and robust surveillance plan and ensure adequate training for staffs involved. Conclusion: To improve SSI prevention in the region, it is imperative to encourage implementation of national programs with standardized methodologies and accountabilities. An ongoing APAC information exchange, including data and methodologies, will enable continuous learning within the APAC region.
KW - Asia Pacific
KW - Infection prevention
KW - SSI surveillance
KW - Surgical site infection
UR - https://www.scopus.com/pages/publications/85111793523
U2 - 10.1016/j.idh.2021.03.003
DO - 10.1016/j.idh.2021.03.003
M3 - Article
C2 - 33931363
AN - SCOPUS:85111793523
SN - 2468-0451
VL - 26
SP - 198
EP - 207
JO - Infection, Disease and Health
JF - Infection, Disease and Health
IS - 3
ER -